PLX Stock Price Prediction 2026
Protalix BioTherapeutics, Inc. Common Stock
AI-powered price predictions based on fundamental analysis and growth projections
- MACD converging near zero line - potential energy building
- Volume showing accumulation (CMF: 0.2396)
- Recent pattern: Doji - Indecision pattern
- Price near resistance at $2.21
Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 276.1% upside potential.
Volume Trend: Accumulation
Institutional Buying Detected - Smart money is accumulating shares
Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $2.32 | -0.6% |
| 90 Days | $2.29 | -2.0% |
| 6 Months | $2.25 | -4.1% |
| 1 Year | $2.15 | -8.1% |
| 2 Years EXTENDED | $2.24 | -4.3% |
| 3 Years EXTENDED | $2.33 | -0.4% |
More PLX Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results